Literature DB >> 6456691

Determination of moxalactam in human body fluids by liquid chromatographic and microbiological methods.

D J Miner, D L Coleman, A M Shepherd, T C Hardin.   

Abstract

High-performance liquid chromatographic methods for determination of the isomers of moxalactam in plasma and urine have been developed. Conventional reverse-phase chromatography was used for plasma assays, and an ion-pairing reagent was included for urine assays. Detection limits were 1.5 micrograms/ml of plasma and 7.5 micrograms/ml of urine. The high-performance liquid chromatographic assays were extensively compared with a microbiological assay (detection limit, 1 microgram/ml), using samples from human volunteers to whom moxalactam had been administered as well as plasma and urine from untreated humans, to which moxalactam was added. The correlations between the assays were quite good, but the precision and accuracy of the high-performance liquid chromatographic methods were superior. Both types of assays were used in a study of the stability of moxalactam-containing samples at various temperatures.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6456691      PMCID: PMC181673          DOI: 10.1128/AAC.20.2.252

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  Determination of cephaloridine in serum and tissue by high-performance liquid chromatography.

Authors:  J S Wold; S A Turnipseed
Journal:  J Chromatogr       Date:  1977-06-01

2.  The simultaneous quantitative determination of cephalothin and cefazolin in serum by high pressure liquid chromatography.

Authors:  J S Wold; S A Turnipseed
Journal:  Clin Chim Acta       Date:  1977-07-15       Impact factor: 3.786

3.  Serum gentamicin assay by high-performance liquid chromatography.

Authors:  S K Maitra; T T Yoshikawa; J L Hansen; I Nilsson-Ehle; W J Palin; M C Schotz; L B Guze
Journal:  Clin Chem       Date:  1977-12       Impact factor: 8.327

4.  High speed liquid chromatographic determination of cephalexin in human plasma and urine.

Authors:  T Nakagawa; J Haginaka; K Yamaoka; T Uno
Journal:  J Antibiot (Tokyo)       Date:  1978-08       Impact factor: 2.649

5.  Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers.

Authors:  J N Parsons; J M Romano; M E Levison
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

6.  Antibacterial activity of a new 1-oxa cephalosporin compared with that of other beta-lactam compounds.

Authors:  H C Neu; N Aswapokee; K P Fu; P Aswapokee
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

7.  Quantitation of antibiotics by high-pressure liquid chromatography: cephalothin.

Authors:  I Nilsson-Ehle; T T Yoshikawa; M C Schotz; L B Guze
Journal:  Antimicrob Agents Chemother       Date:  1978-02       Impact factor: 5.191

8.  Therapy of obstetrical infections with moxalactam.

Authors:  R S Gibbs; J D Blanco; Y S Castaneda; P J St Clair
Journal:  Antimicrob Agents Chemother       Date:  1980-06       Impact factor: 5.191

9.  Moxalactam (6059-S), a novel 1-oxa-beta-lactam with an expanded antibacterial spectrum: laboratory evaluation.

Authors:  T Yoshida; S Matsuura; M Mayama; Y Kameda; S Kuwahara
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191

10.  In vitro activity of LY127935.

Authors:  M Barza; F P Tally; N V Jacobus; S L Gorbach
Journal:  Antimicrob Agents Chemother       Date:  1979-09       Impact factor: 5.191

View more
  5 in total

Review 1.  Importance of drug enantiomers in clinical pharmacology.

Authors:  K Williams; E Lee
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

2.  High performance liquid chromatographic determination of moxalactam in human plasma and cerebrospinal fluid.

Authors:  J Nielsen; G Karlaganis; H M von Hattingberg; U B Schaad
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.

Authors:  H C Standiford; G L Drusano; C I Bustamante; G Rivera; A Forrest; B Tatem; J Leslie; M Moody
Journal:  Antimicrob Agents Chemother       Date:  1986-03       Impact factor: 5.191

4.  Moxalactam penetration into cerebrospinal fluid in patients with bacterial meningitis.

Authors:  J Modai; M Wolff; J Lebas; A Meulemans; C Manuel
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

5.  Comparison of the pharmacokinetics of ceftazidime and moxalactam and their microbiological correlates in volunteers.

Authors:  G L Drusano; H C Standiford; B Fitzpatrick; J Leslie; P Tangtatsawasdi; P Ryan; B Tatem; M R Moody; S C Schimpff
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.